Search results
Results from the WOW.Com Content Network
Common side effects include bleeding and nausea. [6] [7] Other side effects may include bleeding around the spine and allergic reactions. [6] Use is not recommended during pregnancy or breastfeeding. [1] [7] Use appears to be relatively safe in those with mild kidney problems. [7] Compared to warfarin it has fewer interactions with other ...
On December 9, 2016, pharmaceutical company Bristol-Myers Squibb agreed to pay $19.5 million to settle claims with forty-three state attorneys general concerning the alleged off-label promotion of its schizophrenia drug Abilify. [50] The lawsuit alleged the company promoted the drug for use in pediatric populations and to treat dementia and ...
False Claims Act, Prescription Drug Marketing Act: 2012 Amgen [11] $762 million Off-label promotion, kickbacks Aranesp: False Claims Act, FDCA 2010 GlaxoSmithKline [12] $750 million Poor manufacturing practices Kytril, Bactroban, Paxil CR, Avandamet: False Claims Act, FDCA 2005 Serono [13] $704 million Off-label promotion, kickbacks ...
Many of these cases have lead to class action lawsuits and proceedings by the Federal Trade Commision (FTC), resulting in a number of settlements worth millions — or even billions — of dollars ...
Medicare has started its first-ever negotiations with drugmakers over the cost of 10 expensive medications, including Eliquis and Stelara. The prices charged in other countries are not a factor in ...
The U.S. government on Tuesday released a list of 10 prescription medicines that will be subject to the first-ever price negotiations by the Medicare health program that covers Americans aged 65 ...
Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain . [ 2 ]
The Food and Drug Administration has granted approval for the next-generation anticlotting medication Eliquis, the regulator announced in a news release. The drug, administered in the form of a ...